Table 1 Concurrent thymoma and hematological malignancy cases reported between 1990 and 2020, including the present case
Author/year | Age/sex | Thymoma type | Hematological malignancy | Co-immune disorder | Clinical course |
|---|---|---|---|---|---|
Szolkowska et al. 2017 [5] | 52, male | B1/B2 | SLL | – | CR at 2 years |
Chen et al. 2015 [6] | 74, male | A | DLBCL | – | CR at 7 months |
Ito 2015 [7] | 62, male | AB | T-LBL | – | CR at 1 year |
Fraser et al. 2012 | 59, male | B1 | PTCL, NOS | – | Death at 7 months |
Yamato et al. 2006 [8] | 59, male | B3 | DLBCL | – | CR at 5 months |
Rovera et al. 2003 [9] | 65, male | AB | T-LBL | – | Death at 8 months |
Khoury et al. 2003 [10] | 62, male | NA | CLL/SLL | NA | NA |
Friedman et al. 1994 [11] | 95, male | NA | T-LBL | – | Death at 10 days |
The present case, 2020 | 81, female | B1 | DLBCL | MG | CR at 14 months |